• 1
    Indian Council for Medical Research. Assessment of Burden of Non-communicable Diseases. New Delhi: Indian Council of Medical Research, 2004; 2328.
  • 2
    Scragg R, Sowers M, Bell C. Third National Health and Nutrition Examination Survey Serum 25-Hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 28132818.
  • 3
    Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinemia in elderly men. Diabetologia 1997; 40: 344347.
  • 4
    Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820825.
  • 5
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 20172029.
  • 6
    Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 2000; 72: 472475.
  • 7
    Strozecki P, Kretowicz M, Odrowaz-Sypniewska G, Manitius J. The influence of intravenous 1,25(OH)2D3 therapy on glucose metabolism in haemodialysed patients with secondary hyperparathyroidism. Ren Fail 2004; 26: 345348.
  • 8
    Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997; 27: 629633.
  • 9
    Rudnicki PM, Molsted-Pedersen L. Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus. Diabetologia 1997; 40: 4044.
  • 10
    Pittas AG, Harris SS, Stark PC, Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980986.
  • 11
    Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 2003; 26: 748753.
  • 12
    Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001; 24: 539548.
  • 13
    Lee S, Clark SA, Gill RK, Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134: 16021610.
  • 14
    Scragg R, Khaw KT, Murphy S. Life-style factors associated with winter serum 25-hydroxyvitamin D levels in elderly adults. Age Ageing 1995; 24: 271275.
  • 15
    Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC et al . Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 10631069.
  • 16
    Vague P, Nguyen L. Rationale and methods for the estimation of insulin secretion in a given patient: from research to clinical practice. Diabetes 2002; 51: S240244.
  • 17
    Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 21912192.
  • 18
    Misra A, Vikran NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obesity 2006; 30: 106111.
  • 19
    Coleman A, Freeman P, Steel S, Shennan A. Validation of the OMRON MX3 Plus oscillometric blood pressure monitoring device according to the European Society for Hypertension international protocol. Blood Press Monit 2005; 10: 165168.
  • 20
    Yen AM, Chiu YH, Chen LS, Wu HM, Huang CC, Boucher BJ, Chen TH. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006; 83: 11531160.
  • 21
    Tulloch-Reid MK, Hanson RL, Sebring NG, Reynolds JC, Premkumar A, Genovese DJ et al . Both subcutaneous and visceral adipose tissues correlate highly with insulin resistance in African Americans. Obes Res 2004; 12: 13521359.
  • 22
    Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A et al . Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29: 19091914.
  • 23
    Weyer C, Bogardus C, Pratley R. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48: 21972203.
  • 24
    Festa A, D’Agostino RJ, Hanley A, Karter A, Saad M, Haffner S. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004; 53: 15491555.
  • 25
    Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR et al . Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54: 10271037.
  • 26
    Mari A, Pacini G, Brazzele AR, Ahren B. Comparative evaluation of simple insulin sensitivity methods based on oral glucose tolerance test. Diabetologia 2005; 48: 748751.
  • 27
    Dent CE, Gupta MM. Plasma 25-hydroxyvitamin-D-levels during pregnancy in Caucasians and in vegetarian and non-vegetarian Asians. Lancet 1975; 2: 10571060.
  • 28
    Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690693.
  • 29
    Awumey EM, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research centre study. J Clin Endocrinol Metab 1998; 83: 169173.
  • 30
    Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al . Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance—a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361367.
  • 31
    Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin–angiotensin system. J Clin Invest 2002; 110: 229238.
  • 32
    Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007; 85: 5459.
  • 33
    Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D et al . Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95: 787796.